Literature DB >> 33864203

The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients.

Zahra Tamartash1, Ali Javinani1, Farhad Gharibdoost1, Reza Atef Yekta2, Amirmohammad Mohammadzadegan1, Hoda Kavosi3.   

Abstract

Entities:  

Year:  2021        PMID： 33864203     DOI： 10.1007/s11739-021-02727-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  3 in total

1.  Are my patients with rheumatic diseases at higher risk of COVID-19?

Authors:  Gabriel Figueroa-Parra; Gloria Mayela Aguirre-Garcia; Carmen Magdalena Gamboa-Alonso; Adrian Camacho-Ortiz; Dionicio Angel Galarza-Delgado
Journal:  Ann Rheum Dis       Date:  2020-03-22       Impact factor: 19.103

2.  COVID-19: the new challenge for rheumatologists. First update.

Authors:  Francesco Ferro; Elena Elefante; Ilaria Puxeddu; Chiara Baldini; Elena Bartoloni; Claudia Baratè; Sara Galimberti; Rosaria Talarico; Marta Mosca; Stefano Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2020-05-26       Impact factor: 4.473

3.  Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis.

Authors:  Nicoletta Del Papa; Gianluca Sambataro; Antonina Minniti; Wanda Maglione; Francesca Pignataro; Antonella Caminati; Sergio Harari; Domenico Sambataro; Claudio Vitali; Roberto Felice Caporali
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-09-24       Impact factor: 5.346
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.